GVR Report cover Ureteral Access Sheath Market (2026 - 2033)Report

Ureteral Access Sheath Market (2026 - 2033)

Size, Share, & Trends Analysis Report By Product Type (Standard (Single-Lumen), Reinforced, Dual-Lumen), By Clinical Indication (Stone Management), By Age Group, By Size, By End Use (Hospitals, Specialty Clinics), And Segment Forecasts

Market Size, 2025

$609.6M

Market Estimate, 2026

$657.7M

Market Forecast, 2033

$1,068.9M

CAGR, 2026–2033

7.2%

Ureteral Access Sheath Market Summary

The global ureteral access sheath market size was valued at USD 609.6 million in 2025 and is projected to grow from USD 657.7 million in 2026 to USD 1,068.9 million by 2033, at a CAGR of 7.2% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 32.57% in 2025. The ureteral access sheath market is primarily driven by the rising prevalence of urolithiasis and other urological disorders, which have increased the volume of ureteroscopy procedures globally.

Ureteral access sheath market overview highlighting global market size in 2025 (USD 609.56 Million), revenue forecast for 2033 (USD 1,068.85 Million), growth trends (CAGR 7.18% from 2026 to 2033), and regional growth momentumSource: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, icon Download Free Sample Report

Key Market Trends & Insights

  • By product type: Standard (single lumen) segment led the market with the largest revenue share in 2025.
  • By size: 10 to 12 segment led the market with the largest revenue share in 2025.
  • By age group: Adult segment led the market with the largest revenue share in 2025.
  • By clinical indication: Stone management segment led the market with the largest revenue share in 2025.
  • By end use: Hospitals segment led the market with the largest revenue share in 2025.

Regional Highlights

  • Largest regional market: North America (32.57% revenue share, 2025)
  • By country: The U.S. ureteral access sheath industry is a major contributor to the global market.

Market Size & Forecast

  • Market size in 2025: USD 609.6 Million
  • Estimated market size in 2026: USD 657.7 Million
  • Projected market size by 2033: USD 1,068.9 Million
  • CAGR (2026-2033): 7.2%
Ask a question about the ureteral access sheath market
Try asking
✓Every figure cited from GVR research Prefer the report? Download free sample →

The growing adoption of minimally invasive surgeries, coupled with technological advancements that improve procedural efficiency, safety, and reduce operative time, is further accelerating market growth. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year due to kidney stones, highlighting the significant clinical burden of the condition. In nearly 1 in 10 individuals, a kidney stone is expected to develop at some point during their lifetime. The rising prevalence of urolithiasis is a key driver of growth in the ureteral access sheath market, as increasing stone cases directly increase the number of ureteroscopic procedures. Ureteral access sheaths are essential in stone management, enabling efficient scope exchanges and improved intrarenal pressure control. As kidney stone incidence continues to grow due to lifestyle and dietary changes, demand for advanced ureteral access devices is expected to increase significantly. According to the National Kidney Foundation, in 2025, approximately 1 in 10 people have experienced a kidney stone at some point in their lives. The condition is slightly more common among men, with about 11 out of every 100 affected, compared to around 9 out of every 100 women.

Ureteral access sheath market size and growth forecast (2023-2033)

To learn more about this report, icon Download Free Sample Report

The growing adoption of minimally invasive urological procedures is a key driver of the ureteral access sheath market, as these procedures depend on safe, efficient ureteral access. Procedures such as ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy use access sheaths to facilitate smooth instrument exchange and improve intrarenal pressure control. The shift toward shorter hospital stays, reduced complications, and faster recovery continues to accelerate demand for ureteral access sheaths.

For instance, a 2025 study published in the Journal of Urological Surgery compared the impact of multiple sessions of retrograde intrarenal surgery (RIRS) with single-access conventional percutaneous nephrolithotomy (PCNL) on acute kidney injury (AKI) in patients with nephrolithiasis. The retrospective analysis included patients who underwent multiple RIRS procedures within three months in the same renal unit and those who received single-access PCNL between January 2018 and December 2023.

 

Characteristic

PCNL (n = 201)

(n, %)

Multiple RIRS (n = 163)

Gender

Male

134 (66.7%)

39 (61.9%)

Female

67 (33.3%)

24 (38.1%)

Number of Stones

Single

123 (61.2%)

96 (58.9%)

Multiple

78 (38.8%)

67 (41.1%)

Get access to detailed company insights of key market participants. To know more request a free sample copy

Source: Journal of Urological Surgery

The study comparing multiple RIRS procedures with single-access PCNL shows that minimally invasive stone management approaches, such as RIRS, are adopted, particularly when renal function preservation and lower procedural invasiveness are priorities. Since RIRS relies heavily on endoscopic access through the ureter, the need for safe, repeatable ureteral access is critical. The increasing preference for minimally invasive stone treatment techniques, such as RIRS, is expected to drive consistent demand for ureteral access sheaths, as they are essential tools for safe and efficient endoscopic kidney stone management.

Technological advancements are significantly driving the ureteral access sheath market by improving procedural safety, efficiency, and clinical outcomes. Innovations such as enhanced flexible materials, hydrophilic coatings, pressure-controlled and dual-lumen designs help reduce ureteral trauma and maintain optimal intrarenal pressure. These developments support wider adoption of ureteral access sheaths across complex and minimally invasive urological procedures.

For instance, in August 2025, the Journal of the Formosan Medical Association reported that urolithiasis remains a prevalent and economically burdensome condition worldwide, with a high recurrence rate. Advances in flexible ureteroscopes (fURS) and high-power holmium laser (HPHL) technologies have broadened clinical indications, positioning retrograde intrarenal surgery (RIRS) as a preferred treatment for complex upper urinary tract stones. The introduction of flexible and navigable suction (FANS) ureteral access sheaths (UAS) has further improved outcomes by enabling effective intrarenal pressure control and high stone-free rates, with minimal serious adverse events. However, alongside these clinical benefits, the rising costs of disposable fURS and HPHL systems are emerging as a significant concern in contemporary stone management.

Market Dynamics

The growing prevalence of kidney stone disease and the increasing adoption of minimally invasive ureteroscopy procedures are major factors driving the ureteral access sheath market. Rising patient preference for faster recovery procedures, technological advancements in flexible ureteroscopes and laser lithotripsy systems, and increasing outpatient stone management procedures have significantly increased the utilization of ureteral access sheaths across hospitals and ambulatory surgery centers. Additionally, growing physician focus on improving procedural efficiency, reducing intrarenal pressure, and minimizing ureteral trauma during retrograde intrarenal surgery (RIRS) continues to support demand for advanced sheath technologies, including hydrophilic-coated and suction-enabled access sheaths.

According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year due to kidney stones, and approximately one in ten individuals will experience a kidney stone during their lifetime.

The market faces challenges due to procedure-related complications and pricing pressures associated with ureteral access sheath utilization. Risks such as ureteral wall injury, mucosal trauma, infection, and postoperative complications can limit adoption among certain physicians and healthcare facilities, particularly in cost-sensitive settings. Furthermore, increasing competition from low-cost regional manufacturers and reimbursement limitations in several countries place pressure on product pricing and profit margins for manufacturers. The availability of alternative procedural techniques and physician preference variability regarding sheath usage during ureteroscopy procedures may also restrain consistent market penetration across all healthcare settings.

 

Market Concentration & Characteristics

The ureteral access sheath market is moderately concentrated, with a few established medical device companies holding a significant share due to strong brand presence, regulatory expertise, and broad distribution networks. The market is characterized by continuous product innovation, strict regulatory compliance, and a focus on minimally invasive urological procedures.

The degree of innovation in the ureteral access sheath market is advancing rapidly, with manufacturers focusing on enhanced materials, improved flexibility, and ergonomic designs to support safer and more efficient ureteroscopic procedures. Innovations such as dual-lumen configurations, pressure-controlled systems, and coatings that reduce friction are improving clinical outcomes and expanding procedural applications. These technological advancements are driving greater adoption among urologists and fueling competitive growth within the market.

Ureteral Access Sheath Industry Dynamics

To learn more about this report, icon Download Free Sample Report

Regulatory frameworks significantly impact the ureteral access sheath market by ensuring product safety, efficacy, and quality through stringent approval processes such as FDA clearance and CE marking. Compliance with evolving medical device regulations increases development costs and time-to-market and builds clinician and patient confidence in these devices. In addition, post-market surveillance and reporting requirements help identify and mitigate potential risks, further shaping competitive dynamics and innovation strategies within the market.

The ureteral access sheath market has seen moderate merger and acquisition activity as larger medical device companies seek to expand their urology portfolios and gain access to innovative technologies. Strategic acquisitions help companies broaden product offerings, enhance geographic reach, and leverage established distribution networks. This consolidation trend is expected to continue as firms aim to strengthen competitive positioning and capitalize on growing demand for advanced urological solutions.

In January 2026, Boston Scientific announced an agreement to acquire Valencia Technologies Corporation to expand its urology portfolio, particularly in overactive bladder (OAB) treatment. The Boston Scientific acquisition of Valencia Technologies reflects the broader expansion of minimally invasive urology treatments, which, in turn, supports the ureteral access sheath market. As urology procedure volumes increase and healthcare providers invest more in advanced endoscopic infrastructure, procedures such as RIRS are expected to grow. Since ureteral access sheaths are routinely used during RIRS to enable safe and repeated scope access, improving procedural efficiency and safety, the rising adoption of minimally invasive urology interventions is expected to drive demand for UAS products.

The ureteral access sheath market is experiencing rapid product expansion, with companies introducing sheaths featuring advanced materials, enhanced flexibility, and improved lumens to meet diverse clinical needs. Newer offerings focus on reducing ureteral trauma, optimizing irrigation flow, and supporting a wider range of endoscopic instruments. This continuous innovation and broadening of product portfolios are helping manufacturers capture more market share and address evolving surgeon preferences.

Regional expansion in the ureteral access sheath market is gaining momentum as manufacturers target emerging markets in Asia-Pacific, Latin America, and the Middle East, where demand for advanced urological treatments is rising. Increasing healthcare infrastructure investments, growing patient awareness, and improving reimbursement frameworks are encouraging market entry and distribution network growth. Strategic partnerships with local distributors and training initiatives for clinicians are further supporting adoption across these expanding regions.

Product Type Insights

The standard (single lumen) segment dominates the ureteral access sheath market in 2025 due to its widespread use in routine ureteroscopy procedures, particularly for stone management. These sheaths are preferred for their simpler design, cost-effectiveness, and proven clinical reliability across a broad patient population. Their compatibility with most ureteroscopes and ease of handling continue to support strong adoption in both hospital and ambulatory settings.

The dual-lumen segment in the ureteral access sheath market is expected to grow faster during the forecast period, driven by its ability to provide simultaneous irrigation and pressure management during complex ureteroscopy procedures. These sheaths enhance visibility, improve stone clearance efficiency, and help reduce intrarenal pressure, supporting better clinical outcomes. Increasing adoption in advanced stone management and complex urological cases is further accelerating the growth of the dual-lumen segment.

Size Insights

The 10–12 Fr segment dominated in ureteral access sheath market in 2025, as this size range offers an optimal balance between adequate working channel access and patient safety. These sheaths are widely used in standard ureteroscopy stone management procedures because they are compatible with most flexible ureteroscopes. Their broad clinical acceptance and suitability for adult patients continue to support strong market dominance.

The <10 Fr segment of the ureteral access sheath market is expected to grow faster during the forecast period, driven by rising demand for minimally invasive and pediatric urological procedures. Smaller-diameter sheaths help reduce ureteral trauma and postoperative complications, making them increasingly preferred in delicate and complex cases. Technological advancements that enable greater flexibility and durability in thinner sheaths are further supporting the growth of this segment.

Age Group Insights

The adult segment dominated the ureteral access sheath market in 2025, largely due to the higher prevalence of urolithiasis and other urological disorders among adults. Adults account for the majority of ureteroscopy procedures, where access sheaths are routinely used to improve procedural efficiency and safety. In addition, lifestyle factors and age-related risks continue to drive greater demand for ureteral interventions in this segment.

The pediatric segment of the ureteral access sheath market is expected to grow faster during the forecast period, driven by rising diagnoses of pediatric urolithiasis and congenital urological disorders. Growing awareness among clinicians, along with advancements in smaller-diameter and more flexible access sheaths designed specifically for children, is supporting adoption. In addition, rising preference for minimally invasive pediatric urological procedures is further accelerating growth in this segment.

Clinical Indication Insights

The stone management segment dominates the ureteral access sheath market in 2025 and is also expected to grow fastest in the forecast period, driven by the high global burden of kidney and ureteral stones and the rising volume of ureteroscopic procedures. Ureteral access sheaths are widely used in stone removal and laser lithotripsy, as they facilitate smooth instrument exchange and maintain low intrarenal pressure. Their ability to enhance procedural efficiency, reduce operative time, and lower complication risks continues to drive strong adoption in stone management applications.

The other segment in the ureteral access sheath market is witnessing significant growth, supported by expanding applications beyond stone management, including tumor biopsies, ureteral strictures, and diagnostic ureteroscopy. Increasing adoption of minimally invasive urological procedures and improved sheath designs that enhance flexibility and access are contributing to this growth. In addition, rising clinician preference for versatile devices across multiple indications is accelerating the segment's expansion.

End Use Insights

Hospitals dominate the ureteral access sheath market due to their role as the primary centers for managing complex urological conditions and performing high-volume endourological procedures such as ureteroscopy. These settings are equipped with advanced surgical infrastructure, imaging systems, and skilled urologists, enabling safe and efficient use of ureteral access sheaths. In addition, the rising number of inpatient and outpatient kidney stone procedures, along with the preference for minimally invasive surgery, further strengthens hospital demand for these devices.

Ureteral Access Sheath Market Share

To learn more about this report, icon Download Free Sample Report

The ambulatory surgery centers (ASCs) segment is expected to grow the fastest during the forecast period in the ureteral access sheath market, driven by the increasing shift of urological procedures from hospitals to outpatient settings. ASCs offer cost-effective treatment, shorter procedure times, and faster patient recovery, making them an attractive option for minimally invasive ureteroscopic interventions. The growing adoption of advanced endourology technologies and favorable reimbursement policies further support the rapid expansion of this segment.

Regional Insights

North America dominated the negative pressure wound therapy market with the largest revenue share of 32.57% in 2025. TheNorth Americaureteral access sheath market is growing due to the rising incidence of urinary stone disease and a greater preference for minimally invasive urological procedures. Healthcare providers in the region are adopting advanced sheath technologies that improve procedural efficiency and patient outcomes. Strong healthcare infrastructure, higher healthcare spending, and supportive reimbursement frameworks further fuel market growth. In addition, ongoing clinical awareness and investment in urology services continue to strengthen North America’s market position.

Ureteral Access Sheath Market Trends, by Region, 2026 - 2033

To learn more about this report, icon Download Free Sample Report

U.S. Ureteral Access Sheath Market Trends

The U.S. ureteral access sheath market is experiencing significant growth, driven by the increasing prevalence of kidney stone disease and the widespread adoption of minimally invasive urological procedures. Ongoing innovations in sheath design and materials are improving procedural safety and efficiency, encouraging higher clinical adoption. In addition, strong healthcare infrastructure, favorable reimbursement policies, and the growing shift toward outpatient urology procedures continue to support market expansion.

The AUA 2026 kidney stone surgery guideline is expected to support the growth of the U.S. ureteral access sheath market. Ureteroscopy (URS) is a key treatment that supports the use of ureteral access sheaths during URS procedures. The guideline recommends URS as a primary treatment option for many kidney and ureteral stones. It allows the use of ureteral access sheaths, including advanced suction-based designs, during URS, thereby increasing clinical adoption of UAS devices. The U.S. already performs a high and growing volume of stone surgeries, with ureteroscopy procedures rising significantly over the last decade, creating sustained procedural demand for access tools such as UAS.

AUA 2026 Kidney Stone Surgery Guideline – Key Recommendations Summary Table

Category

Recommendation

Evidence Grade

Market / Device Relevance

Flexible Ureteroscope Use

Single-use or reusable both recommended

Grade A

Supports ureteroscope market expansion

Ureteral Access Sheath (UAS)

Placement recommended during URS

Grade B

Direct clinical validation for UAS adoption

Flexible Suction UAS

Considered acceptable option

Grade C

Supports next-gen UAS innovation market

Laser Lithotripsy

Holmium:YAG or Thulium fiber laser allowed

Grade C

Supports laser + accessory ecosystem

Antibiotics Before URS & PCNL

Recommended

Grade B

Supports infection control consumables

Post-URS Stent

Not mandatory after uncomplicated URS

Grade C

Slightly reduce stent usage volume

Emerging Technologies

Suction retrograde systems, robotics, hybrid lasers

Emerging

Supports future UAS + integrated system growth

Upgrade report license to gain access to the complete analysis.

Source:  American Urological Association Education and Research, Inc., 2026

Europe Ureteral Access Sheath Market Trends

The Europe ureteral access sheath market is experiencing growth, driven by an increasing prevalence of kidney stone disease and broader adoption of minimally invasive urological procedures such as flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS). Well-established healthcare infrastructure across Western Europe, supported by reimbursement frameworks, enables high procedure volumes and the routine use of advanced endourology devices. Clinical guidelines from leading professional bodies, such as the European Association of Urology (EAU), continue to emphasize evidence-based management of urolithiasis, supporting best practices and encouraging the use of procedural accessories, such as access sheaths. Growth is also supported by continual investment in hospital and ambulatory surgical center capabilities, increasing availability of hydrophilic-coated and dual-lumen sheaths that improve procedural efficiency and patient outcomes, and technology adoption aimed at reducing complications and recovery times.

The UK ureteral access sheath market is growing as part of the broader expansion of minimally invasive urology procedures, driven by rising volumes of flexible ureteroscopy (fURS) and related interventions for kidney stone disease, ureteral obstruction, and other urological conditions. Adoption of advanced endourological techniques and disposable technologies is supported by investments within the National Health Service (NHS) to enhance procedural capacity, improve treatment outcomes, and modernize surgical practice. Government-led health strategy reforms, including the NHS 10-Year Health Plan, which aims to shift care toward prevention, community services, and digital integration, are expected to improve early disease detection and streamline access to specialist care. NHS initiatives such as the Think Kidneys acute kidney Programme and the Renal Services Transformation Programme focus on enhancing prevention, early diagnosis, and integrated care for kidney conditions, which indirectly support demand for diagnostic and surgical tools used in stone management and endourology. Moreover, efforts to reduce waiting times, expand community-based services, and promote innovation in surgical technologies signal a favorable policy environment for technologies associated with ureteral access and urology procedural growth.

The Germany ureteral access sheath market is experiencing growth supported by a well-established healthcare infrastructure and high procedure volumes. Germany maintains one of the largest and most advanced urology markets in Europe, driven by the widespread adoption of minimally invasive procedures such as flexible ureteroscopy (fURS) and laser-assisted stone management, as clinical practice shifts away from traditional modalities, such as shock wave lithotripsy, toward endoscopic techniques. Population aging and the associated rising incidence of urological conditions, particularly kidney stones, benign prostatic hyperplasia (BPH), and other urinary tract disorders, contribute to increased procedural demand.

According to the Federal Ministry of Health of Germany, in Germany, kidney and ureteral stones affect approximately 1–2% of the population each year, with a higher incidence among men than women.

Asia Pacific Ureteral Access Sheath Market Trends

The Asia Pacific ureteral access sheath market is growing, supported by the rising prevalence of kidney stone disease and other urological conditions, expanding healthcare infrastructure, and the increasing adoption of minimally invasive procedures such as flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS). Countries such as China, India, Japan, and South Korea are major contributors, driven by large patient populations, improving access to advanced endourology services in both urban and tier-2/3 cities, and growing private healthcare investment. Rising healthcare spending and government support for advanced medical technologies are enabling the broader use of endoscopic and disposable devices, while increased procedural volumes in hospitals and ambulatory surgical centers further drive demand for accessories such as ureteral access sheaths. The region’s rapid adoption of digital and single-use solutions, along with collaborations between global manufacturers and local distributors, is also enhancing device availability and affordability.

The India ureteral access sheath market is growing as part of the broader expansion of the urology devices and ureteroscopy market, supported by the rising prevalence of urological conditions such as kidney stones (urolithiasis), benign prostatic hyperplasia, and other urinary tract disorders, particularly among an aging and urbanizing population. Increasing procedural volumes for flexible ureteroscopy (fURS) and related minimally invasive surgeries, driven by greater clinician preference and improved patient outcomes, are contributing to higher demand for accessories, including ureteral access sheaths. Growth in the overall urology devices segment is driven by expanding healthcare infrastructure, with more hospitals and specialty centers adopting advanced endourology equipment and techniques, and rising awareness of early diagnosis and treatment of urological diseases.

“We are seeing an unprecedented rise in kidney stone cases, especially among young adults and children. The soaring heat and insufficient hydration are the primary culprits. What’s particularly concerning is the increasing trend in school children, largely driven by high junk food consumption. Stones are not just a problem of adults anymore,” said Dr. Taif Bendegeri, Senior Consultant Urologist at Asian Institute of Nephrology and Urology.

The China ureteral access sheath market is primarily driven by the increasing prevalence of urinary stone disease (urolithiasis), particularly kidney stones and ureteral stones, which have become more common due to lifestyle changes and metabolic factors, leading to rising volumes of flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS) procedures. In addition to stone disease, conditions such as ureteral obstruction from strictures or tumors and complications associated with metabolic disorders further fuel demand for minimally invasive endourology devices.

The Healthy China 2030 initiative is also strengthening the market by prioritizing improvements in healthcare infrastructure, expanding access to quality medical services, and promoting preventive and early diagnostic care, which collectively enhance capacity for urological diagnostics and treatments. This government strategy aims to expand the overall health services system and health industry, improve healthcare access and equity, and accelerate innovation in medical technology, thereby creating a favorable policy environment that supports broader adoption of advanced urology devices, including ureteral access sheaths.

Latin America Ureteral Access Sheath Market Trends

The Latin America ureteral access sheath market is growing, driven by expanding healthcare infrastructure and the increasing adoption of hydrophilic-coated ureteral access sheaths, which improve ease of insertion and reduce ureteral trauma. Rising procedural volumes of flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS) for kidney stone management are key contributors to market growth, particularly in countries such as Brazil and Argentina. Improved availability of advanced endourology devices, growing investment in private hospitals, and increasing clinician preference for minimally invasive techniques are further supporting adoption.

Middle East & Africa Ureteral Access Sheath Trends

The Middle East & Africa (MEA) ureteral access sheath market is experiencing growth, driven by increasing investments in healthcare infrastructure, particularly in Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the UAE, where advanced urology and minimally invasive surgical capabilities are expanding. Rising awareness of urological disorders, including kidney stone disease, and a gradual shift toward minimally invasive endourology procedures are driving demand for ureteral access sheaths across the region. In addition, the development of private hospitals, the growth of medical tourism, and collaborations between international device manufacturers and regional distributors are improving access to advanced urology devices.

Key Ureteral Access Sheath Company Insights

The ureteral access sheath market is highly competitive, with key players holding significant positions. The major companies are undertaking various organic as well as inorganic strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion for serving the unmet needs of their customers.

Key Ureteral Access Sheath Companies:

The following key companies have been profiled for this study on the ureteral access sheath market.

  • Boston Scientific Corporation
  • BD
  • Olympus
  • Coloplast
  • Cook Medical
  • Advin Health Care
  • Judges Scientific plc (GEOTEK)
  • ACE Medical Devices
  • Blue Neem Medical Devices Private Limited
  • AMECATH
  • Creo Medical
  • Applied Medical Resources Corporation
  • Volkmann Medizintechnik Gmbh.
  • Urovision-Urotech
  • Rocamed SAM
  • Well Lead Medical Co.,Ltd.
  • Richard Wolf GmbH
  • SCW Medicath Ltd
  • Innovex Medical

Competitive Benchmarking

Operating Strategies

Competitive Edge

Weaknesses

Mature Player: BD

  • Mature participants in the ureteral access sheath market primarily focus on portfolio expansion, surgeon loyalty programs, direct hospital contracting, and integration with broader stone management product ecosystems, including guidewires, ureteroscopes, laser fibers, and stone retrieval devices.
  • These companies emphasize premium product positioning supported by clinical evidence, physician training workshops, and partnerships with high-volume urology centers.
  • Established manufacturers benefit from strong brand recognition, long-standing relationships with urologists, broad distribution networks, and integrated urology portfolios that enable bundled sales strategies.
  • Regulatory expertise, large-scale manufacturing capabilities, extensive reimbursement knowledge, and higher investments in R&D and clinical validation studies further strengthen their competitive advantage
  • Mature companies face pricing pressure from low-cost regional manufacturers and emerging disposable-focused competitors. Larger organizational structures can slow innovation cycles and delay response to evolving physician preferences for next-generation sheath technologies.
  • Premium pricing strategies may also limit penetration in cost-sensitive ambulatory surgery centers and emerging international markets

Emerging player: Creo Medical

  • Emerging players focus on niche innovation, aggressive pricing strategies, and targeted expansion within high-growth ambulatory surgery and outpatient urology settings.
  • Many newer entrants prioritize differentiated technologies such as suction-assisted ureteral access sheaths, enhanced flexibility designs, anti-kink engineering, and cost-efficient disposable platforms
 
  • Emerging companies compete through pricing flexibility, innovation speed, and specialized product differentiation tailored toward unmet procedural challenges. Their lean operational structures allow faster commercialization of new designs and quicker adaptation to surgeon preferences.
  • In developing markets, localized manufacturing and distributor-driven models can provide advantages in procurement accessibility and tender competitiveness
  • Emerging participants generally face limitations related to lower brand recognition, restricted sales infrastructure, limited clinical validation data, and smaller distribution networks.
  • These companies may encounter challenges in securing hospital contracts, GPO participation, and physician trust compared to established multinational manufacturers. Financial constraints can also limit investment in large-scale marketing, regulatory expansion, and long-term R&D programs

Recent Developments

  • In September 2025, Olympus Corporation announced an exclusive global distribution partnership with MacroLux Medical Technology to expand its single-use urology product portfolio. The agreement covers single-use cystoscopes, ureteroscopes, and suction access sheaths used to diagnose and treat urinary tract conditions, such as kidney stones.

  • In September 2025, Dornier MedTech announced the full U.S. commercial launch of two single-use urology devices: the Hoover Flexible and Navigable Suction Ureteral Access Sheath and the Axis II Slim ureteroscope. The Hoover sheath enables continuous irrigation, suction, and instrument exchange during stone procedures, improving visibility and reducing procedure time.

“Dornier MedTech America has a deep understanding of urological workflows and urologists’ needs. The Dornier Hoover delivers best-in-class suction performance and Dornier Axis II Slim offers best-in-class deflection—giving urologists a proven competitive edge in the operating theater,” CEO Brock Faulkner 

Ureteral Access Sheath Market Report Scope

Report Attribute

Details

Market size in 2025

USD 609.6 million

Estimated Market size in 2026

USD 657.7 million

Projected Market size by 2033

USD 1,068.9 million

Growth rate

CAGR of 7.2% from 2026 to 2033

Actual data

2021 - 2025

Forecast period

2026 - 2033

Quantitative units

Revenue in USD million/billion and CAGR from 2026 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product type, size, age group, clinical indication, end use, and region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

Key companies profiled

Boston Scientific Corporation; BD; Olympus; Coloplast; Cook Medical; Advin Health Care; Judges Scientific plc (GEOTEK); ACE Medical Devices; Blue Neem Medical Devices Private Limited; AMECATH; Creo Medical; Applied Medical Resources Corporation; Volkmann Medizintechnik GmbH; Urovision-Urotech; Rocamed SAM; Well Lead Medical Co., Ltd.; Richard Wolf GmbH; SCW Medicath Ltd; Innovex Medical

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Ureteral Access Sheath Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the ureteral access sheath market report on the basis of product type, size, age group, clinical indication, end use and region:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)

    • Standard (Single-Lumen)

    • Reinforced

    • Dual‑Lumen

  • Size Outlook (Revenue, USD Million, 2021 - 2033)

    • <10

    • 10 to 12

    • More than or equal to 13 - 15

  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)

    • Adult

    • Pediatric

  • Clinical Indication Outlook (Revenue, USD Million, 2021 - 2033)

    • Stone Management

    • Others

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)

    • Hospitals

    • Specialty Clinics

    • Diagnostic Centers

    • ASCs

    • Others

  • Region Outlook (Revenue, USD Million, 2021 - 2033)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Delivered Customizations

This report has been delivered with the following In-depth customizations

Client Request

Customization Delivered

Value Adds

Global Ureteral Access Sheath Market Assessment for the U.S., Europe, Japan & Emerging Asia

Developed a comprehensive market intelligence assessment focused on disposable and reusable ureteral access sheaths used in ureteroscopy and kidney stone management procedures across the U.S., Europe, Japan, China, and selected Asia-Pacific countries. The study included market sizing and forecasts (2021–2033), procedure volume analysis for ureteroscopy and retrograde intrarenal surgery (RIRS), epidemiology of urolithiasis, ASP benchmarking, hospital procurement trends, reimbursement assessment, and regulatory scenario mapping. The analysis further evaluated sheath diameter utilization trends, hydrophilic coating adoption, single-use versus reusable penetration, physician preference patterns, and ambulatory surgery center adoption trends influencing demand for ureteral access sheaths

Enables stakeholders to understand country-wise utilization trends for ureteroscopic procedures, identify high-growth stone management markets, evaluate reimbursement-driven adoption, and align commercialization strategies with evolving minimally invasive urology procedure trends and regional clinical practice patterns

Competitive Benchmarking & Brand Share Analysis for Ureteral Access Sheaths

Delivered an in-depth competitive benchmarking assessment covering major manufacturers operating in the ureteral access sheath market, including Boston Scientific, Cook Medical, Olympus, Coloplast, Teleflex, BD, ROCAMED, and Advin Health Care. The study incorporated manufacturer-level revenue analysis, regional brand share benchmarking, product portfolio mapping by sheath size and coating technology, pricing analysis, distribution network assessment, physician adoption trends, and competitive positioning analysis. The assessment also benchmarked product differentiation parameters such as kink resistance, insertion force, flexibility, radiopacity, and infection prevention features

Provides actual intelligence into dominant product brands, technology positioning, and pricing competitiveness, enabling stakeholders to benchmark market leaders, identify white-space opportunities, optimize distributor partnerships, and prioritize product development initiatives based on unmet physician needs and procedural trends

U.S. Ureteral Access Sheath Market Volume Analysis, Product-Type Segmentation & Cross-Segmentation Intelligence Study

Conducted a detailed U.S.-specific ureteral access sheath market assessment incorporating market size (USD & Units), procedure-linked demand modeling, product-type volume analysis, and cross-segmentation intelligence across size and end-user settings. The assessment further analyzed utilization across hospitals, ambulatory surgery centers, and specialty urology clinics while benchmarking procedure volumes for flexible ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy procedures. Additional customization included ASP benchmarking by product category, procurement pattern analysis, physician preference mapping, and company-level positioning across premium, mid-tier, and value-based product segments. The report also incorporated a triangulated forecasting methodology using bottom-up procedure volume modeling, company revenue benchmarking, distributor validation, surgeon interviews, and reimbursement trend analysis

Supports strategic decision-making through transparent product-level demand analysis, volume forecasting, and utilization benchmarking across key procedure settings. Enables stakeholders to identify high-growth product categories, optimize product portfolio positioning, evaluate adoption trends by sheath configuration and care setting, benchmark competitive penetration, and align manufacturing, pricing, and commercialization strategies with evolving ureteroscopy procedure dynamics across the U.S. market

Frequently Asked Questions About This Report

About the Author(s)

Medical Devices Research Team

Healthcare · Medical Devices

This report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo